Stacey Johnson
Stacey Johnson is the editor of Signals and a contributor. For 25 years, Stacey has been providing strategic communications counsel to government, corporate, technology and health organizations. She began her career at the CTV Television Network and then moved to Hill & Knowlton Canada where she advised clients in a variety of industries and sectors. Stacey is the Vice President, Communications and Marketing for CCRM, a leader in developing and commercializing regenerative medicine-based technologies and cell and gene therapies. She has a Master's degree in Public Relations. You can follow her on Twitter @msstaceyerin.
Posts by: Stacey
Reimbursing CGTs and other highlights from Cell and Gene Therapy World 2018
Cell and Gene Therapy World, or “Phacilitate” as delegates like to refer to it, happened last week in Miami, Florida (January 22-25). The conference, with 1,500 in attendance, brings together industry professionals from more than 30 countries. The event explores trends and opportunities that are shaping the future of cell and gene therapies (CGTs). […]
Right Turn: A new science twist on those old Christmas favourites
This time of year is special for many reasons, and traditions are a big part of that. It’s risky to mess with traditions; many people look forward to, and value, the familiarity and ritual of repeating something they have done for years, or even decades. You might think that introduction means I’m heading to the Signals archives […]
Right Turn: Four STEM women to watch
If I say the names Kirsty Duncan, Mona Nemer, Julie Payette and Molly Shoichet, what comes to mind? There are many ways to answer that question, of course, but the answer I’m looking for is that they are all female scientists or engineers who hold significant posts in government with the ability to influence […]